Prime Medicine Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Prime Medicine Inc's ROI in the second quarter of 2026?
Prime Medicine Inc recorded a cumulative net loss of $-83 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -29.5%.

Within the Healthcare sector 363 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 2189 to 3749.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	3.46 %	6.56 %	10.52 %	19.84 %	26.66 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	217	258	305	350	245
Return On Investment (TTM)	-29.5 %	-50.57 %	-67.38 %	-190.29 %	-219.8 %
PRME's Overall Ranking	# 3749	# 2189	# 2823	# 3594	# 2879
Seq. Investment Change TTM	-2.38 %	-2.97 %	3.98 %	5.04 %	0.55 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-83	-146	-201	-546	-601

PRME Company Profile >> Back to PRME Roi Comparisons >> See Annual PRME Return On Investment

Return On Investment PRME's Ranking
Within:	No.
Industry	# 40
Sector	# 364
Overall	# 3749

Return On Investment Statistics
High	Average	Low
0.13 %	-64.82 %	-219.8 %
(Dec 31 2023)		(Jun 30 2025)

Financial Statements
Prime Medicine Inc's II. Quarter Investments	$ 217 Millions	PRME's Balance sheet
Prime Medicine Inc's II. Quarter Income	$ -42 Millions	Quarterly PRME's Income Statement
PRME's Income by Division		See PRME's Income by Division

PRME Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2020) 2022
Total Investments in Millions	305	260	137	581	0
Y / Y Investment Growth	17.62 %	88.86 %	-76.36 %	-	-
Net Income in Millions	-201	-392	0	-3	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-65.89 %	-150.94 %	0.2 %	-0.59 %	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PRME's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PRME's Competitors
Subscribers only: Roi for Prime Medicine Inc's Suppliers
Subscribers only: Return On Investment for PRME's Customers

Other Ratios
PRME's Roa	PRME's Inventory Turnover Ratio	PRME's Growth Rates	PRME's Dividend Statistics
	PRME's Profitability Ratios	PRME's Asset Turnover Ratio	PRME's Dividend Growth
PRME's Roe	PRME's Valuation Ratios	PRME's Financial Strength Ratios	PRME's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-26T07:42:02+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.